How Dr. Anand’s experience in ProActive Study informed his center’s Prospera surveillance protocol

Описание к видео How Dr. Anand’s experience in ProActive Study informed his center’s Prospera surveillance protocol

In this episode, Dr Sanjiv Anand, Medical Director of the Living Donor Transplant Program at Intermountain Health, share his insights on:

-Protocol for patients 13-months post-transplant
-Use of cfDNA as an “immune dial”
-Case examples where close monitoring guided care decisions to provide peace of mind to his patients

Комментарии

Информация по комментариям в разработке

Похожие видео